The Asia Pacific Neurostimulation Devices Market would witness market growth of 13.9% CAGR during the forecast period (2020-2026). Increased mental health awareness and the prevalence of neurological diseases along with numerous initiatives taken up by the government and private entities have been contributing to the exponential market growth. Factors such as improved healthcare infrastructure, an increasing number of healthcare reforms, and extensive healthcare spending in emerging markets such as India and China to overcome unmet medical needs in these regions are boosting demand for neurostimulators.
The rapid rise of COVID-19 infections leads to an increased concern for the shortage of essential life-saving devices and other vital health care to prevent the spread of this pandemic and provide the infected with optimum care. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide variety of test-kits (antibody samples, self-administered, and others) require a rapid acceleration in the manufacturing process.
In conjunction with the available limited treatment options for the disease, the high product efficiency in the treatment of epilepsy is expected to boost market growth throughout the forecast period. Essential tremor is characterized by severe unintentional limb movement. The condition has an impact on the neck, jaw, and other parts of the body. The rising global population of geriatric diseases is among the most significant causes of tremor. Rising depression cases are also likely to contribute to the market development as neurostimulation equipment can easily handle electrical brain signals by activating or inhibiting them.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Neurostimulation Devices Market in Asia Pacific is expected to register a CAGR of 13.9% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Market Segmentation:
By Devices
By Applications
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
